Purpose: Nasopharyngeal carcinoma (NPC) is one of the most common head and neck cancers and is thought to be related to the mucosal immune system. Radiation therapy (RT) is the primary treatment for NPC due to the high radiosensitivity of cancer cells. However, little is known about the impact of RT on the mucosal immune system. Patients and methods: In this study, the expression of immune markers CD19, CD24, CD27, CD8, and IgA before and after RT, were analyzed using flow cytometry. Cytokines were assessed using the enzyme-linked immunosorbent assay. Reactive oxygen species (ROS) was assayed by flow cytometry and fluorescence staining using 2ʹ,7ʹ -dichlorofluorescein diacetate. Results: We found that primary NPC patients had a significant increase in CD19 
Introduction
Nasopharyngeal carcinoma (NPC) is associated with the Epstein-Barr virus (EBV) and is characterized by epistaxis, nasal obstruction and discharge, and headache. 1 NPC has a marked geographic distribution, where it is endemic to North Africa, Southern Asia and southern China. 2 Due to its anatomic characteristics and highly sensitivity to radiation therapy (RT), NPC is generally treated with RT but rather than with surgery. 3, 4 The mechanism of RT for tumor treatment is complex. Studies have demonstrated that high dose irradiation directly breaks double-stranded DNA in tumor cells triggering apoptosis. 5, 6 On the contrary, low dose irradiation leads to the release of damage-associated molecular pattern molecules, cytokines and reactive oxygen species (ROS) from tumor cells which may interact with immune cells. [7] [8] [9] However, the specific immune responses elicited after RT treatment in patient with NPC as well as its relationship with prognosis remains unknown. Nasopharyngeal-associated lymph reticular tissue is a major mucosal inductive site, and has mucosal immune characteristics, such as high expression levels of secreted IgA (sIgA), which protects against EBV in NPC patients. 10 However ROS is an electrophilic chemical species with a short half-life and is generated by incomplete oxidation. It has long been implicated as a secondary messenger involved in cell signaling activation and cell fate decisions. 15, 16 ROS can control B cell development, activation and apoptosis through activation of the B cell receptor or caspases signaling pathways. [17] [18] [19] In 
Materials and methods

Patients and controls
Peripheral blood was obtained from 38 primary NPC patients (mean, 47.8years; range, 15-64 years). Of those, 24 patients had blood recollected after RT. All patients had pathologically confirmed NPC and had not received prior treatment. Table 1 summarizes the characteristics of NPC patients. All patients were staged using the 7th edition of the Staging System of the American Joint Committee of Cancer. The study was approved by the medical ethics council of Fudan University Shanghai Cancer Center. Informed consent was obtained from all patients and healthy volunteers recruited in this study.
Cell isolation and flow cytometry
PBMCs were isolated using discontinuous Lymphoprep (Axis-ShieldPoCAs, Oslo, Norway) gradient centrifugation and were re-suspended in phosphate-buffered saline (PBS) containing 2% fetal bovine serum. Isolated PBMCs were collected by centrifugation, incubated with Fc-blocking antibody (purified anti-human CD16/32, BioLegend, San Diego, CA, USA) to prevent nonspecific binding and then incubated with the following antibodies (CD19: CF506236, BD Biosciences, CA, USA, 1:50; CD24: BDB563371, BD Biosciences, 1:50; CD27: BDB340424, BD Biosciences, 1:50; CD8: BDB564805, BD Biosciences, 1:50; IgA: ab193189, Abcam, CA, USA, 1:50) for 30 min on ice.
After staining, cells were analyzed using CyAn-ADP (Beckman Coulter). Intracellular cytokine staining was performed by using the stimulation cocktail (eBioscience, San Diego, CA, USA) pre-stimulated for three hours as the manufacturer's recommended protocol. Samples were analyzed by CyAn-ADP (Beckman Coulter) and data were processed using Flow Jo software (TreeStar, Ashland, OR). 
In vitro ionizing radiation
Isolated PBMCs were further purified using the human pan B cell kit(StemCell Technologies, Vancouver, BC, Canada). Briefly, purified B cells were placed into 6cm diameter petri-dishes, and exposured to 4-Gy of ionizing radiation. In the diphenyleneiodonium chloride (DPI) group, cells were pretreated with 1 mM DPI30 min prior to exposure to ionizing radiation. After 18 hrs, the supernatant and cells were harvested for measurement of Cell viability using trypan blue staining. 
Flow cytometry analysis of ROS
Statistical analysis
Two group comparisons were performed using Student's ttest. Multiple group comparisons were performed using one-way analysis of variance, followed by Bonferroni correction or Mann-Whitney U testing to compare two individual groups. Statistical analysis was performed using Prism 6.0 (La Jolla, CA). The P-values of 0.05 were considered statistically significant. Figure 1A , CD19 + CD138 − IgA + B cells were significantly increased in primary NPC blood cells (onset), and were subsequently decreased to a level below the control after RT. We then assessed serum cytokine expressions and found that the sIgA levels did not change with RT treatment; however, the production of TGF-β and IL-10 increased before RT and subsequently decreased to the control level after RT ( Figure 1C ), This trend is consistent with changes in cytokines. The percentage of CD19 + IgA − cells were not affected on the other hand ( Figure S1 ). 
Results
Enumeration
Changes in the percentage changes of CTLs and other immune effector cells
Next, we assessed the changes in the percentage of other immune effector cells. As shown in Figure 2A and B, the proportion of CD8 + Granzyme B (GB) + /CD8, CD8 + IFN-ɣ + /CD8 and CD8 + TNF-α + /CD8 were significantly increased in primary NPC (before), indicating that CD8 cells differentiate to anti-tumor CTLs after cancer onset. Importantly, the percent of CTL/CD8 cells increased to a greater extent after RT and was negatively correlated with the percentage of CD19 + CD138 − IgA + B cells ( Figure 2D ). Secreted levels of Granzyme B, IFN-ɣ and TNF-α were detected by ELISA, and results demonstrate upregulation of IFN-ɣ and Granzyme B after RT ( Figure 2C ). We also detected ROS were reported to be released by the ionizing radiation (IR) used in RT, we evaluated ROS production in the peripheral blood of patients before and after RT and found increased levels following radiation therapy ( Figure S4 ). Next, we exposed petri-dishes containing PMBC to 4Gy ionizing radiation, and detected ROS expression inside B cells and in the microenvironment. After in vitro ionizing radiation, the immune cells and their supernatants were harvested to assess ROS levels. As shown in Figure 3A , ROS was found in the supernatant and the cytoplasm of CD19 cells following exposure to ionizing radiation. However, the functions of these cells were unaffected when pretreated with DPI ( Figure 3C ). Levels of sIgA did not change following radiation treatment, indicating that production of sIgA is not the main function of IgA + B cells in cancer ( Figure 3C ). 
Discussion
In this study, we illustrated the suppressive function of immune cells in NPC patients and determined the changes in the immune cell profile before and after RT. We found that during the onset of NPC, the percentage of 
CD27
+ Breg subset, which was involved in defining populations of B cells in this study.
14 Interestingly, our current results showed that Breg cells are not involved in the RT process, despite being the only B cell subset that survived after RT. We are currently working on possible explanations of this phenomenon. Conversely, Tregs are important for suppression of antitumor immunity, thus were considered for analysis in this study. Results indicate that the expression of Tregs was similar to that of Bregs. In addition, we found that the expression of myeloid-derived suppressor cells remained unchanged before and after RT treatment (data not shown), indicating that they are not related to the mechanisms of radiotherapy in nasopharyngeal cancer.
CTLs are the critical effector cells in tumor immunity, and we have previously demonstrated that they can be utilized as an efficient means to treat tumors. Therefore, we sought to determine whether the decrease of CD19 + CD138 − IgA + B cells after RT was accompanied by an increase of CTL cells. It was found that the proportion of CTL cells increased, along with the secretion of cytokines and particles. Moreover, the expression of CTL was inversely proportional to the expression of CD19 + CD138 − IgA + Bcells, suggesting a possible correlation between the two, which will require further investigation. RT is used to directly or indirectly eliminate cancer cells. One of the ways in which cancer can be targeted indirectly is through the release of ROS. 7 Tominaga et al found that gene instability in tumor cells caused by RT could be reduced using various anti-ROS methods. 21 Studies by Wang et al have shown that cancer cells can utilize changes in ROS metabolism activity to resist radiation therapy. In addition, Danhier et al outlined that cancer cells can perform a series of actions to achieve the following goals: produce sufficient energy to promote cell proliferation (biological energetics), generate debris (biosynthesis), and generate a reduction of molecular pool from oxidative stress. [22] [23] [24] Most importantly, many studies have found that ROS generated by RT can lead to changes in the immune microenvironment. 25 
Patients and controls
All participants, and a parent or legal guardian of participants under the age of 18 years, had written informed consent for donating their samples to Fudan University Shanghai Cancer Center. 
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